February 28, 2024

By Nigam Arora & Dr. Natasha Arora

To gain an edge, this is what you need to know today.

Biotech Breakout

Please click here for a chart of biotech ETF (XBI).

Note the following:

• The chart shows biotech has broken out.
• The chart shows the move up was on high volume, indicating conviction in the move.
• The chart shows when XBI was in the Arora buy zone.  This represents a 54% gain in about four months for members of The Arora Report.  XBI is in the ZYX Allocation Core Model Portfolio.
• RSI on the chart shows that biotech is overbought.
• The breakout in biotech shows there are opportunities for investors beyond AI, Nvidia (NVDA), and big tech.